BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (vol 103, pg 668, 2010)

S-J Dawson, N Makretsov, FM Blows, KE Driver, E Provenzano, J Le Quesne, L Baglietto, G Severi, GG Giles, CA McLean, G Callagy, AR Green, I Ellis, K Gelmon, G Turashvili, S Leung, S Aparicio, D Huntsman, C Caldas, P Pharoah